Translational Research
Volume 152, Issue 4 , Pages 151-156 , October 2008

Association between transforming growth factor-beta 1 polymorphism and virologic characteristics of chronic hepatitis C

  • Chia-Yen Dai

      Affiliations

    • Hepatobiliary Division, Department of Internal Medicine, the Department of Occupational and Environmental Medicine, and the Faculty of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Tian-Sheng Memorial Hospital, Pintong, Taiwan
    • ,
  • Wan-Long Chuang

      Affiliations

    • Hepatobiliary Division, Department of Internal Medicine, the Department of Occupational and Environmental Medicine, and the Faculty of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Tian-Sheng Memorial Hospital, Pintong, Taiwan
    • ,
  • Li-Po Lee

      Affiliations

    • Hepatobiliary Division, Department of Internal Medicine, the Department of Occupational and Environmental Medicine, and the Faculty of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Tian-Sheng Memorial Hospital, Pintong, Taiwan
    • ,
  • Wen-Cheng Pan

      Affiliations

    • Hepatobiliary Division, Department of Internal Medicine, the Department of Occupational and Environmental Medicine, and the Faculty of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Tian-Sheng Memorial Hospital, Pintong, Taiwan
    • ,
  • Jee-Fu Huang

      Affiliations

    • Hepatobiliary Division, Department of Internal Medicine, the Department of Occupational and Environmental Medicine, and the Faculty of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Tian-Sheng Memorial Hospital, Pintong, Taiwan
    • ,
  • Ming-Yen Hsieh

      Affiliations

    • Hepatobiliary Division, Department of Internal Medicine, the Department of Occupational and Environmental Medicine, and the Faculty of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Tian-Sheng Memorial Hospital, Pintong, Taiwan
    • ,
  • Nai-Jen Hou

      Affiliations

    • Hepatobiliary Division, Department of Internal Medicine, the Department of Occupational and Environmental Medicine, and the Faculty of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Tian-Sheng Memorial Hospital, Pintong, Taiwan
    • ,
  • Zu-Yau Lin

      Affiliations

    • Hepatobiliary Division, Department of Internal Medicine, the Department of Occupational and Environmental Medicine, and the Faculty of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Tian-Sheng Memorial Hospital, Pintong, Taiwan
    • ,
  • Shinn-Cherng Chen

      Affiliations

    • Hepatobiliary Division, Department of Internal Medicine, the Department of Occupational and Environmental Medicine, and the Faculty of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Tian-Sheng Memorial Hospital, Pintong, Taiwan
    • ,
  • Ming-Yuh Hsieh

      Affiliations

    • Hepatobiliary Division, Department of Internal Medicine, the Department of Occupational and Environmental Medicine, and the Faculty of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Tian-Sheng Memorial Hospital, Pintong, Taiwan
    • ,
  • Liang-Yen Wang

      Affiliations

    • Hepatobiliary Division, Department of Internal Medicine, the Department of Occupational and Environmental Medicine, and the Faculty of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Tian-Sheng Memorial Hospital, Pintong, Taiwan
    • ,
  • Wen-Yu Chang

      Affiliations

    • Hepatobiliary Division, Department of Internal Medicine, the Department of Occupational and Environmental Medicine, and the Faculty of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Tian-Sheng Memorial Hospital, Pintong, Taiwan
    • ,
  • Ming-Lung Yu

      Affiliations

    • Hepatobiliary Division, Department of Internal Medicine, the Department of Occupational and Environmental Medicine, and the Faculty of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Department of Internal Medicine, Tian-Sheng Memorial Hospital, Pintong, Taiwan
    • Corresponding Author InformationReprint requests: Ming-Lung Yu, MD, Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, No. 100, Tz-You 1st Rd, Kaohsiung 807, Taiwan

Received 22 March 2008 ,Revised 2 August 2008 ,Accepted 12 August 2008.

References 

  1. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States (The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team). N Engl J Med. 1992;327:1899–1905
  2. Koziel MJ. Cytokines in viral hepatitis. Semin Liver Dis. 1999;19:157–169
  3. Osna N, Silonova G, Vilgert N, et al. Chronic hepatitis C: T-helper1/T-helper2 imbalance could cause virus persistence in peripheral blood. Scand J Clin Lab Invest. 1997;57:703–710
  4. Tsushima H, Kawata S, Tamura S, et al. Reduced plasma transforming growth factor-beta1 levels in patients with chronic hepatitis C after interferon-alpha therapy: association with regression of hepatic fibrosis. J Hepatol. 1999;30:1–7
  5. Tsai SL, Liaw YF, Chen MH, Huan CY, Kuo GC. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology. 1997;25:449–458
  6. Larrea E, Garcia N, Qian C, Civeira MP, Prieto J. Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C. Hepatology. 1996;23:210–217
  7. Dai CY, Chuang WL, Lee LP, et al. Associations of tumour necrosis factor alpha promoter polymorphisms at position −308 and −238 with clinical characteristics of chronic hepatitis C. J Viral Hepat. 2006;13:770–774
  8. Dai CY, Chuang WL, Hsieh MY, et al. Polymorphism of interferon-gamma gene at position +874 and clinical characteristics of chronic hepatitis C. Transl Res. 2006;148:128–133
  9. Dai CY, Chuang WL, Chang WY, et al. Tumor necrosis factor alpha promoter polymorphism at position −308 predicts hepatitis C virus response to combination therapy. J Infect Dis. 2006;193:98–101
  10. Dai CY, Chuang WL, Chang WY, et al. Polymorphisms in the interferon-gamma gene at position +874 in patients with chronic hepatitis C treated with high-dose interferon-alpha and ribavirin. Antiviral Res. 2005;67:93–97
  11. Bedossa P, Paradis V. Transforming growth factor-beta (TGF-beta): a key-role in liver fibrogenesis. J Hepatol. 1995;22:37–42
  12. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994;331:1286–1292
  13. Fujii D, Brissenden JE, Derynck R, Francke U. Transforming growth factor beta gene maps to human chromosome 19 long arm and to mouse chromosome 7. Somat Cell Mol Genet. 1986;12:281–288
  14. Perrey C, Pravica V, Sinnott PJ, Hutchinson IV. Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes: a technical report. Transpl Immunol. 1998;6:193–197
  15. Tambur AR, Ortegel JW, Ben-Ari Z, et al. Role of cytokine gene polymorphism in hepatitis C recurrence and allograft rejection among liver transplant recipients. Transplantation. 2001;71:1475–1480
  16. Tilg H, Wilmer A, Vogel W, et al. Serum levels of cytokines in chronic liver disease. Gastroenterology. 1992;103:264–274
  17. Shirai Y, Kawata S, Tamura S, et al. Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma (Comparsion with chronic liver diseases). Cancer. 1994;73:2275–2279
  18. Powell EE, Edwards-Smith CJ, Hay JI, et al. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology. 2000;31:828–833
  19. Kanzler S, Baumann M, Schirmacher P, et al. Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-β. J Viral Hepat. 2001;8:430–437
  20. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1:431–435
  21. Okamoto H, Tokita H, Sakamoto M, et al. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol. 1993;74:2385–2390
  22. Barrett S, Coloins M, Kenny C, Ryan E, Keane CO, Crowe J. Polymorphisms in tumour necrosis factor-α, transforming growth factor-β, interleukin-10, interleukin-6, interferon-γ, and outcome of hepatitis C virus infection. J Med Virol. 2003;71:212–218
  23. Rook AH, Kehrl JH, Wakefield LM, et al. Effects of transforming growth factor on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol. 1986;136:3916–3920
  24. Kimura T, Saito T, Yoshimura M, et al. Association of transforming growth factor–1 functional polymorphisms with natural clearance of hepatitis C virus. J Infect Dis. 2006;193:1371–1374
  25. Okumoto K, Hattori E, Tamura K, et al. Possible contribution of circulating transforming growth factor-1 to immunity and prognosis in unresectable hepatocellular carcinoma. Liver Int. 2004;24:21–28
  26. Song BC, Chung YH, Kim JA, et al. Transforming growth factor-beta1 as a useful serologic marker of small hepatocellular carcinoma. Cancer. 2002;94:175–180
  27. Murata T, Ohshima T, Yamaji M, et al. Suppression of hepatitis C virus replicon by TGF-. Virology. 2005;331:407–417
  28. Gewaltig J, Mangasser-Stephan K, Gartung C, Biesterfeld S, Gressner AM. Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis. Clin Chim Acta. 2002;316:83–94
  29. Suzuki S, Tanaka Y, Orito E, et al. Transforming growth factor-beta1 genetic polymorphism in Japanese patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol. 2003;18:1139–1143
  30. Bakr I, Rekacewicz C, El Hosseiny M, et al. Higher clearance of hepatitis C virus infection in females compared with males. Gut. 2006;55:1183–1187
  31. Yamakawa Y, Sata M, Suzuki H, Noguchi S, Tanikawa K. Higher elimination of hepatitis C virus among women. J Viral Hepat. 1996;6:317–321
  32. Paladino N, Fainboim H, Theiler G, et al. Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 (IL-10) promoter polymorphism. J Virol. 2006;80:9144–9150

 Supported by National Science Council Grant NSC- 93-2314-B037-076 and the Taiwan Liver Research Foundation.

PII: S1931-5244(08)00208-9

doi: 10.1016/j.trsl.2008.08.001

Translational Research
Volume 152, Issue 4 , Pages 151-156 , October 2008

Article Tools